Enorama Pharma
2.35 SEKBe the first to follow this company
Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are mainly sold through retailers who sell the product under their own brand. The largest market is established in the Nordic region, but also worldwide. Enorama Pharma was founded in 2006 and the head office is located in Malmö.
Revenue
1.36M
EBIT %
-3,097.79 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ERMA
Daily low / high price
-
Market cap
142.11M SEK
Turnover
-
Volume
-
Financial calendar
Interim report
2024-05-22
General meeting
2024-06-05
Interim report
2024-08-21
Interim report
2024-11-20
Annual report
2025-02-19
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
madHat AB | 30.0 % | 30.0 % |
Swede Unipharma AB | 20.4 % | 20.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Enorama Pharma AB (publ) senarelägger årsstämma till den 5 juni 2024
Enorama Pharma AB (publ) meddelar sista dag för handel med BTA
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools